Regulatory decisions & notices (medical devices & IVDs)

6 June 2018

Regulatory decisions for medical devices & IVDs

Notices and advice for industry about medical devices & IVDs

2018 2017 2016 2015 2014



  • Automatic conditions for medical devices - legislative amendments
    14 July 2017: Legislative amendments have come into effect that automatically impose a number of standard conditions on all medical device entries in the ARTG. These conditions relate to storage and transport requirements, record keeping, annual reporting, and notification of information relating to certain IVD medical devices.
  • Annual Charges for IVDs effective from 1 July 2017
    8 June 2017: Annual charges for IVDs included on the Australian Register of Therapeutic Goods (ARTG) will commence from 1 July 2017. The annual charge per ARTG entry for the 2017/2018 financial year will be $660 for all classes of IVDs.


  • Medical device quality management systems: transition to new standard
    8 December 2016: In March of this year the International Organization for Standardization (ISO) published a new revision to ISO 13485, the medical device quality management systems (QMS) standard for regulatory purposes, which replaces the previous version from 2003.<
  • Annual charges for IVDs effective from 1 July 2017
    21 July 2016: The transition period for the in vitro diagnostic medical devices (IVDs) regulatory framework will cease on 30 June 2017. During the transition period there are no annual charges for entries in the Australian Register of Therapeutic Goods (ARTG) for IVDs. Annual Charges will commence from 1 July 2017. Further information on the proposed annual charges for IVD medical devices will be provided when available. For information on current fees for applications for conformity assessment or inclusion in the ARTG, please refer to Summary of fees and charges from 1 January 2016.
  • New Tyvek® materials: regulatory obligations
    22 January 2016: In order to meet the conditions of inclusion on the ARTG, manufacturers need to check that the performance and safety of their medical devices continue to meet the Australian Essential Principles (EPs)